Insider Buying and Selling - REPL

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
05/20/2025	05/22/2025	Astley-Sparke Philip Director	Sell	-32,279 @ $8.06	($260,168.74)	1,405,071	(-2.25%)	Direct
05/20/2025	05/22/2025	Hill Emily Luisa Chief Financial Officer CFO	Sell	-2,535 @ $8.05	($20,406.75)	143,522	(-1.74%)	Direct
05/20/2025	05/22/2025	Patel Sushil Chief Executive Officer CEO Director	Sell	-25,105 @ $8.06	($202,346.30)	343,576	(-6.81%)	Direct
05/20/2025	05/22/2025	Sarchi Christopher Chief Commercial Officer Officer	Sell	-3,749 @ $8.05	($30,179.45)	128,296	(-2.84%)	Direct
05/20/2025	05/22/2025	Schwendenman Andrew Chief Accounting Officer Officer	Sell	-3,287 @ $8.05	($26,460.35)	68,284	(-4.59%)	Direct
05/20/2025	05/22/2025	Xynos Konstantinos Chief Medical Officer Officer	Sell	-7,952 @ $8.06	($64,093.12)	146,933	(-5.13%)	Direct
12/16/2024 10b5-1	12/18/2024	Patel Sushil Chief Executive Officer CEO Director	Sell	-10,000 @ $12.42	($124,200.00)	202,014	(-4.72%)	Direct
11/18/2024	11/20/2024	Sarchi Christopher Chief Commercial Officer Officer	Sell	-5,207 @ $10.78	($56,131.46)	87,045	(-5.64%)	Direct
11/18/2024	11/20/2024	Xynos Konstantinos Chief Medical Officer Officer	Sell	-7,246 @ $10.78	($78,111.88)	109,885	(-6.19%)	Direct
08/16/2024	08/19/2024	Hill Emily Luisa Chief Financial Officer CFO	Sell	-8,938 @ $10.18	($90,988.84)	101,057	(-8.13%)	Direct

Replimune Group, Inc. - REPL